PLCO Publications
Here you can browse the complete list of publications for PLCO
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. | 27357932 | Falk RT, Staff AC, Bradwin G, Karumanchi SA, Troisi R | Cancer causes & control : CCC | 2016 | PLCO |
| Associations of intakes of magnesium and calcium and survival among women with breast cancer: results from Western New York Exposures and Breast Cancer (WEB) Study. | 27073728 | Tao MH, Dai Q, Millen AE, Nie J, Edge SB, Trevisan M, Shields PG, Freudenheim JL | Am J Cancer Res | 2016 | PLCO |
| Essential Nutrient Interactions: Does Low or Suboptimal Magnesium Status Interact with Vitamin D and/or Calcium Status? | 26773013 | Rosanoff A, Dai Q, Shapses SA | Adv Nutr | 2016 | PLCO |
| Calcium/magnesium intake ratio, but not magnesium intake, interacts with genetic polymorphism in relation to colorectal neoplasia in a two-phase study. | 26333203 | Zhu X, Shrubsole MJ, Ness RM, Hibler EA, Cai Q, Long J, Chen Z, Li G, Jiang M, Hou L, Kabagambe EK, Zhang B, Smalley WE, Edwards TL, Giovannucci EL, Zheng W, Dai Q | Mol Carcinog | 2016 | PLCO |
| Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials. | 25312998 | Ten Haaf K, van Rosmalen J, de Koning HJ | Cancer Epidemiol. Biomarkers Prev. | 2015 | NLST, PLCO |
| Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. | 26602092 | Lotan Y, Karam JA, Shariat SF, Gupta A, Roupret M, Bensalah K, Margulis V | Urol. Oncol. | 2015 | NLST, PLCO |
| Data Processing and Analytic Support in the PLCO Cancer Screening Trial. | 26238116 | Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC | Rev Recent Clin Trials | 2015 | PLCO |
| The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results. | 26238115 | Gohagan JK, Prorok PC, Greenwald P, Kramer BS | Rev Recent Clin Trials | 2015 | NLST, PLCO |
| The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource. | 26238117 | Carrick DM, Black A, Gohagan JK, Khan A, Pettit K, Williams C, Yu K, Yurgalevitch S, Huang WY, Zhu C | Rev Recent Clin Trials | 2015 | PLCO |
| Comprehensive Quality Management (CQM) in the PLCO Trial. | 26238118 | Gohagan JK, O'Brien B, Hasson MA, Umbel KD, Bridgeman B, Kramer BS, Reding D, Gren L, Wright P, Riley T, Prorok PC | Rev Recent Clin Trials | 2015 | PLCO |
| Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | 26238119 | Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Lawrence W, Miller A, ProroK PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P | Rev Recent Clin Trials | 2015 | PLCO |
| Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center. | 26238206 | Gren LH, Lamerato LE, Wright P, Marcus PM | Rev Recent Clin Trials | 2015 | PLCO |
| Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial. | 26238207 | Bazzi L, Lamerato LE, Varner J, Shambaugh VL, Cordes JE, Ragard LR, Marcus PM | Rev Recent Clin Trials | 2015 | PLCO |
| Building Successful Relationships in the PLCO Cancer Screening Trial. | 26238208 | Marcus PM, Broski KG, Buys SS, Childs J, Church TR, Gohagan JK, Gren LH, Higgins D, Jaggi R, Jenkins V, Johnson CC, Lappe K, O'Brien B, Ogden SL, Prorok PC, Reding D, Shambaugh V, Yokochi LA, Yurgalevitch S | Rev Recent Clin Trials | 2015 | PLCO |
| Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. | 26291054 | Hashibe M, Galeone C, Buys SS, Gren L, Boffetta P, Zhang ZF, La Vecchia C | Br. J. Cancer | 2015 | PLCO |
| Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial. | 26291583 | Shoag J, Halpern J, Eisner B, Lee R, Mittal S, Barbieri CE, Shoag D | JAMA Oncol | 2015 | PLCO |
| Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study. | 26320383 | Morales EE, Grill S, Svatek RS, Kaushik D, Thompson IM, Ankerst DP, Liss MA | Eur. Urol. | 2015 | PLCO |
| Focused Decision Support: a Data Mining Tool to Query the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Dataset and Guide Screening Management for the Individual Patient. | 26385814 | Sharma A, Hostetter J, Morrison J, Wang K, Siegel E | J Digit Imaging | 2015 | PLCO |
| Participants' Views of Retention Materials Used in the PLCO Cancer Screening Trial. | 26387707 | Pretzel SM, Andrews TS, Broski K, Childs JC, Gren LH, Ogden SL, Mabie J, Thomas B, Rozjabek HM, Marcus PM | Clin Med Res | 2015 | PLCO |
| Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial. | 26435288 | Gohagan JK, Broski K, Gren LH, Fouad MN, Higgins D, Lappe K, Ogden S, Shambaugh V, Pinsky PF, O'Brien B, Yurgalevich S, Riley T, Wright P, Prorok PC | Rev Recent Clin Trials | 2015 | PLCO |